Roivant Sciences (ROIV) Enterprise Value (2020 - 2026)
Roivant Sciences (ROIV) recorded Enterprise Value of $22.42 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 513.4% from $3.66 billion a year earlier and up 36.5% from the prior quarter.
Roivant Sciences (ROIV) Enterprise Value (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' Enterprise Value came in at $9.22 billion as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was $16.43 billion, up 523.5% from FY2025.
- Annual Enterprise Value has a five-year compound annual growth rate of 30.4% (FY2021 to FY2026).
- Across earlier fiscal years, Enterprise Value came in at $2.63 billion in FY2025 (+5.9%), $2.49 billion in FY2024 (-43.2%), $4.38 billion in FY2023 (+149.8%) and $1.75 billion in FY2022 (-59.6%).
- The fiscal Q1 2027 figure is the highest quarterly Enterprise Value in data going back to fiscal Q3 2021.
- On a year-over-year basis, Enterprise Value has increased for seven consecutive quarters, with growth averaging 169.4% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 714.6% in fiscal Q2 2024, against a decline of 76.2% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $16.43 billion (Q4 2026), $11.58 billion (Q3 2026) and $6.49 billion (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.42 Bn |
| Mar 31, 2026 | 16.43 Bn |
| Dec 31, 2025 | 11.58 Bn |
| Sep 30, 2025 | 6.49 Bn |
| Jun 30, 2025 | 3.66 Bn |
| Mar 31, 2025 | 2.63 Bn |
| Dec 31, 2024 | 3.71 Bn |
| Sep 30, 2024 | 3.50 Bn |
| Jun 30, 2024 | 2.57 Bn |
| Mar 31, 2024 | 2.49 Bn |
| Dec 31, 2023 | 2.83 Bn |
| Sep 30, 2023 | 8.32 Bn |
| Jun 30, 2023 | 6.72 Bn |
| Mar 31, 2023 | 4.38 Bn |
| Dec 31, 2022 | 4.75 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 1.28 Bn |
| Mar 31, 2022 | 1.75 Bn |
| Dec 31, 2021 | 5.14 Bn |
| Sep 30, 2021 | 4.29 Bn |
Roivant Sciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ROIV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();